Medivantis Pharma Private Limited
About Medivantis Pharma Private Limited
Data last updated:
Medivantis Pharma Private Limited was a private limited company based in Panipat, Haryana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 09 January 2021.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24299HR2021PTC092101. Its GSTIN is 06AAOCM1979P1ZJ (Haryana).
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Sahil Mann and Daya Nand Mann.
The registered office was at Ds9/IV Tharmal Colony, Panipat, Haryana, India – 132103.
As per the financials filed for FY 2025, the company reported a revenue of ₹50.04 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹8,040 (net margin 0.2%) and EBITDA of ₹69,724 (EBITDA margin 1.4%).
As per MCA filings, the company had open charges of ₹15 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.
Company details
Contact details
Medivantis Pharma Private Limited's registered office is in Panipat, Haryana.
- Registered AddressDs9/IV Tharmal Colony, Panipat, Haryana, India – 132103
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medivantis Pharma Private Limited
Medivantis Pharma Private Limited reported revenue of ₹50.04 Lakh (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year. EBITDA rose 42% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹69,724 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,040 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medivantis Pharma Private Limited, buy the company report.
Board of directors of Medivantis Pharma Private Limited
Medivantis Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sahil Mann | Director | 09 Jan 2021 | 5 Years 9 Months | As last reported |
| Daya Nand Mann | Director | 09 Jan 2021 | 5 Years 9 Months | As last reported |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Nov 2022 | 100650925 | Others | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Medivantis Pharma Private Limited has 1 court case on record: 1 filed by Medivantis Pharma. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Chandigarh | Company petition | Filed by the company against Registrar of Companies New Delhi | Disposed |
To see the full case history of Medivantis Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medivantis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medivantis Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAOCM1979P1ZJ | Haryana | Active | 27 Apr 2021 |
To see the full GST registrations and return filing status of Medivantis Pharma Private Limited, buy the company report.
Recent activity
Medivantis Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Daya Nand Mann was appointed as Director on 09 Jan 2021.
Frequently asked questions
Medivantis Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Medivantis Pharma was a private limited company based in Panipat, Haryana, India. The company worked in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 09 January 2021 and is registered under CIN U24299HR2021PTC092101. The company has been struck off by the Registrar of Companies and is no longer operational.
Medivantis Pharma had 2 directors:
- Sahil Mann - Director
- Daya Nand Mann - Director
The CIN (Corporate Identification Number) of Medivantis Pharma is U24299HR2021PTC092101. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Medivantis Pharma is at Ds9IV Tharmal Colony, Panipat, Haryana, India – 132103.
Medivantis Pharma was incorporated on 09 January 2021. It is registered with the Registrar of Companies, Delhi.
The GSTIN of Medivantis Pharma is 06AAOCM1979P1ZJ, registered in Haryana.
Medivantis Pharma operated in the chemicals industry, in the fine chemicals and other chemical products segment. It worked in this industry before it was struck off.
Medivantis Pharma has 1 court case on record: 1 filed by the company.
Daya Nand Mann was appointed as Director on 09 Jan 2021. Sahil Mann was appointed as Director on 09 Jan 2021.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
